Ubs Oconnor LLC Roivant Sciences Ltd. Transaction History
Ubs Oconnor LLC
- $1.46 Billion
- Q3 2024
A detailed history of Ubs Oconnor LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Ubs Oconnor LLC holds 146,937 shares of ROIV stock, worth $1.66 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
146,937Holding current value
$1.66 Million% of portfolio
0.12%Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
316Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$743 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$741 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$610 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$470 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$399 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.94B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...